News Why relying on AI outcome models may not be a good idea The use of AI outcome prediction models (OPMs) in medicine is on the rise, but a new paper has warned widespread use could lead to patient harm.
Digital Alongside diagnosis: AI’s role in shaping health transformat... Humans are about to go hybrid – in fact, our race is undergoing its own digital transformation.
R&D Defining innovation: The battle for clarity, access, and sta... The pharmaceutical industry often claims its medicines as highly innovative and expects to be compensated accordingly.
Oncology LSX2026: Addressing adult eye cancer, with Roi Raz Roi Raz, CEO of ReBio Pharma, discusses injectable, bioresorbable sustained release delivery for ophthalmic therapeutics at LSX 2026.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.